Enhancing the Role of Commune Health Workers in HIV and Drug Control: A Randomized Controlled Trial

Sponsor
University of California, Los Angeles (Other)
Overall Status
Completed
CT.gov ID
NCT02130921
Collaborator
National Institute of Hygiene and Epidemiology, Vietnam (Other)
1,800
2
2
46
900
19.6

Study Details

Study Description

Brief Summary

This proposed study is an initiative for HIV prevention and care that integrates intervention efforts at multiple strata: Community Health Workers (CHWs), Injecting Drug Users (IDUs), and their Family Members (FMs). The proposed study will demonstrate the process of development, implementation, and evaluation of an intervention for CHWs, IDUs, and their FMs. One aim is to increase the CHWs' capacities to effectively interact with IDUs and FMs for HIV and drug use prevention and treatment. Using a combination of participatory action research and a randomized controlled trial design, this study has the potential to maximize PEPFAR impact in Vietnam and other PEPFAR-funded countries by identifying a sustainable mix of interventions and their implementation in different settings. The findings may benefit not only Vietnam but also a global audience by investigating enhanced methods for controlling the HIV epidemic.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intervention to Address Drug Use and HIV in Vietnam
N/A

Detailed Description

Vietnam is currently facing an HIV epidemic that had affected approximately 280,000 people by the end of 2009. Injecting Drug Use (IDU) is principal driver of the HIV epidemic, contributing to between 32 % and 58 % of all HIV cases in various provinces. However, it has proven difficult to address the needs of IDUs, a high-risk group, given the prevalence of stigmatization and drug use in Vietnamese society. In addition, Vietnamese people are highly family oriented and most young IDUs have daily family contact of live in their parents' homes. Thus the burden on the family is substantial, and even greater if the IDU is HIV+.

The study will be implemented in two provinces in Vietnam: Phu Tho and Vinh Phuc. A randomized controlled trial will be conducted to evaluate the impact of the intervention in 60 commune health centers. From each center we will recruit 5 Community Health Workers (CHWs), 15 Injecting Drug Users (IDUs), and 10 Family Members (FMs) (totaling 300 CHWs, 900 IDUs, and 600 FMs). The outcomes will be evaluated at 3-, 6-, 9-, and 12- month follow-up assessments. The specific aims of the study are as follows:

  1. To develop and implement an integrated intervention, CHW CARE, for CHWs, IDUs, and their FMS in Vietnam

  2. To evaluate the feasibility and operational procedures of the intervention with an implementation pilot, including process evalution and monitoring, and participants feedback.

  3. To assess the impact of the intervention by comparing outcome measures of CHWs, IDUs, and FMs in the intervention group to those in the control group.

  4. To explore the relationships between the intervention outcomes of CHWs, IDUs, and FMs.

Study Design

Study Type:
Interventional
Actual Enrollment :
1800 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Enhancing the Role of Commune Health Workers in HIV and Drug Control: A Randomized Controlled Trial
Actual Study Start Date :
Jul 1, 2014
Actual Primary Completion Date :
May 1, 2018
Actual Study Completion Date :
May 1, 2018

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Community Health Workers (CHWs) in the control group will be invited to one group lecture didactically reviewing medical ethics, and the attending CHWs will be requested to pay a home visit to participating IDUs and FMs after the lecture.

Experimental: Intervention

Intervention for CHWs: 3 sessions will cover the understanding stigma and its impact, self-protection and universal precaution adherence, effective communication with patients and family members, and motivational enhancement for behavioral change. Intervention for IDUs: CHWs who participate in the intervention will be required to conduct 3 individual sessions with participating IDUs covering the following topics: physical health, risk reduction behaviors, mental health, and community integration. Intervention for FMs: CHWs who participate in the intervention will be required to conduct 2 group sessions with participating FMs covering the following topics: healthy family routine, coping with caregiver burdens, enhance family relationships, support positive behavior change.

Behavioral: Intervention to Address Drug Use and HIV in Vietnam
Intervention for CHWs: 3 sessions will cover the understanding stigma and its impact, self-protection and universal precaution adherence, effective communication with patients and family members, and motivational enhancement for behavioral change. Intervention for IDUs: CHWs who participate in the intervention will be required to conduct 3 individual sessions with participating IDUs covering the following topics: physical health, risk reduction behaviors, mental health, and community integration. Intervention for FMs: CHWs who participate in the intervention will be required to conduct 2 group sessions with participating FMs covering the following topics: healthy family routine, coping with caregiver burdens, enhance family relationships, support positive behavior change.

Outcome Measures

Primary Outcome Measures

  1. Community Health Worker (CHW) Interaction with patients [Changes from baseline to 3-, 6-, 9- and 12- month follow-up]

    Provider-Client interaction scale will be used.

  2. Injecting Drug User (IDU) drug use [baseline, 3-, 6-, 9- and 12- month follow-up]

    Urine test results

Secondary Outcome Measures

  1. Community Health Worker (CHW) job safety, support, and satisfaction [Changes from baseline to 3-, 6-, 9-, and 12- month follow-up]

    This will be assessed by perceived risk at work and institutional support. Additionally by job satisfaction using a 29-item scale.

  2. Community Health Worker (CHW) knowledge and adherence to universal precautions [Changes from baseline to 3-, 6-, 9-, and 12- month follow-up]

    This will be assessed with the universal precautions knowledge scale.

  3. Injecting Drug User (IDU) family and social support [Changes from baseline to 3-, 6-, 9- and 12- month follow-up]

    This is measured by two instruments. Social Support Questionnaire (Short; SSQ6) is a 6-item assessment to measure satisfaction of social support. Number of social support providers is captured up to 9 people in various support dimensions (Sarason et al., 1983). Medical Outcomes Study- Social Support Scale (MOS-SS) is a 20-item scale that measures the strength of perceived social support available. The scale consists of five dimensions: emotional support, informational support, tangible support, positive social interaction, and affection

  4. Family Member (FM) social support [Changes from baseline to 3-, 6-, 9-, and 12- month follow-up]

    This is measured by two instruments. Social Support Questionnaire (Short; SSQ6) is a 6-item assessment to measure satisfaction of social support. Number of social support providers is captured up to 9 people in various support dimensions (Sarason et al., 1983). Medical Outcomes Study- Social Support Scale (MOS-SS) is a 20-item scale that measures the strength of perceived social support available. The scale consists of five dimensions: emotional support, informational support, tangible support, positive social interaction, and affection.

  5. Community Health Worker (CHW) general prejudicial attitude [Changes from baseline to 3-, 6-, 9- and 12- month follow-up]

    A scale will be used

  6. Family Member (FM) Caregiver burden/coping [Changes from baseline to 3-,6-,9-, and 12-month follow-up]

    Caregiver burden and coping scales will be used

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Injecting Drug Users:
  • Age 18 or over

  • Having a history of drug use

  • Currently residing in the selected commune, and have no plan to move to other communes in the following year

  • Voluntary informed consent

Family members of Injecting Drug Users:
  • Age 18 or over

  • Immediate or extended family member of the Injecting Drug User.

  • Previous knowledge of the drug use of the IDU.

  • Voluntary informed consent

  • Currently residing in the selected commune, and have no plan to move to other communes in the following year

Community Health Workers:
  • Age 18 or over

  • Doctor, nurse, or other care provider working at the selected commune health centers

  • Informed consent

Exclusion Criteria:
Injecting Drug Users:
  • Those who have psychosis or neurological damage, or cannot understand the study purposes as judged by the interviewer in consultation with a clinic supervisor, will be excluded

  • Does not meet other inclusion criteria

Family members of Injecting Drug Users:
  • Those who have psychosis or neurological damage, or cannot understand the study purposes as judged by the interviewer in consultation with a clinic supervisor, will be excluded

  • Does not meet other inclusion criteria

Community Health Workers:
  • Inability to give informed consent

  • Does not meet other inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 Phú Thọ commune health centers Phú Thọ Vietnam
2 Vĩnh Phúc commune health centers Vĩnh Phúc Vietnam

Sponsors and Collaborators

  • University of California, Los Angeles
  • National Institute of Hygiene and Epidemiology, Vietnam

Investigators

  • Principal Investigator: Li Li, Ph.D, University of California, Los Angeles

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Li Li, PhD, Professor in Residence, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT02130921
Other Study ID Numbers:
  • R01DA033609-01
First Posted:
May 6, 2014
Last Update Posted:
Oct 12, 2018
Last Verified:
Oct 1, 2018
Keywords provided by Li Li, PhD, Professor in Residence, University of California, Los Angeles
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 12, 2018